Description: Brightgreen Corporation
Site will be available soon. Thank you for your patience!
With legacy expertise in pharmaceutical ingredient production and scalable operations, Bright Green is breaking new ground as a licensed manufacturer of plant-based drugs and Active Pharmaceutical Ingredients (APIs) in the U.S.
As the first publicly traded company in the U.S. to receive DEA federal authorization for the growth, manufacturing, and sale of cannabis and related products for pharmaceutical applications, and research, Bright Green is the largest player in the industry.